Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32673170

Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Sep 1
First author
Grob JJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Grob JJ
      type
      Author
    2. name
      Gonzalez R
      type
      Author
    3. name
      Basset-Seguin N
      type
      Author
    4. name
      Vornicova O
      type
      Author
    5. name
      Schachter J
      type
      Author
    6. name
      Joshi A
      type
      Author
    7. name
      Meyer N
      type
      Author
    8. name
      Grange F
      type
      Author
    9. name
      Piulats JM
      type
      Author
    10. name
      Bauman JR
      type
      Author
    11. name
      Zhang P
      type
      Author
    12. name
      Gumuscu B
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Grob JJ
      type
      Author
    2. name
      Gonzalez R
      type
      Author
    3. name
      Basset-Seguin N
      type
      Author
    4. name
      Vornicova O
      type
      Author
    5. name
      Schachter J
      type
      Author
    6. name
      Joshi A
      type
      Author
    7. name
      Meyer N
      type
      Author
    8. name
      Grange F
      type
      Author
    9. name
      Piulats JM
      type
      Author
    10. name
      Bauman JR
      type
      Author
    11. name
      Zhang P
      type
      Author
    12. name
      Gumuscu B
      type
      Author
    bibliography ids
    1. nci-bib-7bfdbc3029f0e97e4c60552e
    book metadata
    content sha256
    0a90c599492ac630ad21e29a8c4040adc48d32e2ed34ebaf420b2ea596b63755
    document type
    citation
    dois
    1. 10.1200/JCO.19.03054
    electronic publication date
    display
    2020 Jul 16
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:32673170
    immutable id
    pubmed:32673170@0a90c599492ac630ad21e29a8c4040adc48d32e2ed34ebaf420b2ea596b63755
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    25
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2916-2925
    volume
    38
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      32673170
      provenance
      batch id
      40d9eae1f1d369f13109
      provider
      NCBI PubMed ESummary
      record sha256
      5df16a5d0510aaf328a9f1ae26d22d02f7ba88ac3d0fbc49c4b2cec896f93d87
      response sha256
      03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
      retrieved at
      2026-09-09T23:47:52.637547+00:00
      publication date
      display
      2020 Sep 1
      precision
      day
      year
      2020
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/32673170/
      title
      Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629).

      Preserved source evidence · Not medical advice